Tunisia Pharmaceutical Market size was valued at US$ 1.69 Bn in 2021 and the total revenue is expected to grow at 12.9 % through 2022 to 2029, reaching nearly US$ 4.47 Bn.
These are the findings of a recent overview of the Tunisian pharmaceutical market by the Maximisemarketsearch website.
According to the same source, Tunisia is one of the few countries in Africa with sophisticated management and advanced technologies pharmaceutical sector, both in terms of product quality and safety.
The generic drug local production is approximately 49% and importations are around 51%.
Tunis has approx. 39 pharmaceutical companies in the region.
